Zhen Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhen Wang has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Alves da Silva
University of Mississippi Medical Center
19 shared publications - Jussara Marcia Do Carmo
University of Mississippi Medical Center
16 shared publications John E. Hall
University of Mississippi Medical Center
13 shared publications- Xuan Li
University of Mississippi Medical Center
13 shared publications - Alan J. Mouton
University of Mississippi Medical Center
12 shared publications - Ana Carolina Mieko Omoto
University of Mississippi Medical Center
12 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (5) , H1591-H1607
Impaired mitochondrial proteostasis underlies cardiomyocyte bioenergetic dysfunction in a murine three-hit model of heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction (HFpEF) lacks effective therapies in part due to an incomplete understanding of cardiomyocyte-specific mitochondrial mechanisms involved in cardiac dysfunction. Using an aged, multihit mouse model that recapitulates key features of human HFpEF in both sexes, we demonstrate that impaired cardiac reserve is associated with reduced mitochondrial respiratory capacity and coordinated suppression of mitochondrial protein quality-control pathways. These findings identify mitochondrial proteostasis failure as a central mechanism limiting energetic reserve in HFpEF cardiomyocytes.
- 1 November 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (5) , H1591-H1607
Open AccessImpaired mitochondrial proteostasis underlies cardiomyocyte bioenergetic dysfunction in a murine three-hit model of heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction (HFpEF) lacks effective therapies in part due to an incomplete understanding of cardiomyocyte-specific mitochondrial mechanisms involved in cardiac dysfunction. Using an aged, multihit mouse model that recapitulates key features of human HFpEF in both sexes, we demonstrate that impaired cardiac reserve is associated with reduced mitochondrial respiratory capacity and coordinated suppression of mitochondrial protein quality-control pathways. These findings identify mitochondrial proteostasis failure as a central mechanism limiting energetic reserve in HFpEF cardiomyocytes.
- Open Access
- 20 October 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
Exogenous lactate exacerbates adverse cardiac remodeling following myocardial infarction via impaired macrophage activation and myocardial ER stress
Myocardial infarction (MI) induces cardiac remodeling characterized by inflammation, scar formation, and metabolic remodeling of surviving tissue. Emerging evidence suggests that lactate, an alternative metabolic fuel, may also have therapeutic effects by mitigating damaging inflammation. To investigate the effects of lactate on post-MI remodeling, male and female mice underwent permanent coronary artery ligation for up to 7-days post-MI. In untreated animals, MI induced progressive myocardial lactate accumulation, accompanied by increased Lactate Dehydrogenase-A (LDHA) and reduced LDHB expression in both male and female. In untreated male, cardiac macrophages exhibited dynamic changes in Ldha, Ldhb, and Mct1 gene expression between Day-1, 3, and 7. Repeated sodium lactate administration significantly reduced Day-7 survival in male and promoted ventricular wall thinning, reduced collagen deposition, increased myocardial inflammatory markers ( Ccl2, Il18, Il6) and reduced CD206+ reparative macrophages in both infarct and remote regions at Day-3. To distinguish acute from sustained lactate effects, we administered a single sodium lactate injection 30 minutes before tissue collection at Day-3 post-MI (D3-30min), which rapidly increased myocardial lactate levels and induced inflammatory and endoplasmic reticulum stress–associated gene expression. Moreover, acute lactate treatment (D3-30min) increased circulating and bone marrow neutrophils, increased bone marrow and cardiac monocytes, and reduced ATP-linked mitochondrial respiration in isolated cardiac macrophages. In parallel experiments, sodium oxamate (a lactate dehydrogenase inhibitor), displayed a trend towards improving post-MI survival (p=0.09) but otherwise did not significantly impact cardiac functional or remodeling parameters. These findings demonstrate that exogenous lactate exacerbates adverse post-MI remodeling, promoting extracellular matrix disruption, inflammatory activation, and macrophage metabolic dysregulation. Collectively, our results suggest that lactate metabolic signaling, production, accumulation or downstream may represents a potential therapeutic strategy for limiting adverse cardiac remodeling after MI.
- 20 October 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
Open AccessExogenous lactate exacerbates adverse cardiac remodeling following myocardial infarction via impaired macrophage activation and myocardial ER stress
Myocardial infarction (MI) induces cardiac remodeling characterized by inflammation, scar formation, and metabolic remodeling of surviving tissue. Emerging evidence suggests that lactate, an alternative metabolic fuel, may also have therapeutic effects by mitigating damaging inflammation. To investigate the effects of lactate on post-MI remodeling, male and female mice underwent permanent coronary artery ligation for up to 7-days post-MI. In untreated animals, MI induced progressive myocardial lactate accumulation, accompanied by increased Lactate Dehydrogenase-A (LDHA) and reduced LDHB expression in both male and female. In untreated male, cardiac macrophages exhibited dynamic changes in Ldha, Ldhb, and Mct1 gene expression between Day-1, 3, and 7. Repeated sodium lactate administration significantly reduced Day-7 survival in male and promoted ventricular wall thinning, reduced collagen deposition, increased myocardial inflammatory markers ( Ccl2, Il18, Il6) and reduced CD206+ reparative macrophages in both infarct and remote regions at Day-3. To distinguish acute from sustained lactate effects, we administered a single sodium lactate injection 30 minutes before tissue collection at Day-3 post-MI (D3-30min), which rapidly increased myocardial lactate levels and induced inflammatory and endoplasmic reticulum stress–associated gene expression. Moreover, acute lactate treatment (D3-30min) increased circulating and bone marrow neutrophils, increased bone marrow and cardiac monocytes, and reduced ATP-linked mitochondrial respiration in isolated cardiac macrophages. In parallel experiments, sodium oxamate (a lactate dehydrogenase inhibitor), displayed a trend towards improving post-MI survival (p=0.09) but otherwise did not significantly impact cardiac functional or remodeling parameters. These findings demonstrate that exogenous lactate exacerbates adverse post-MI remodeling, promoting extracellular matrix disruption, inflammatory activation, and macrophage metabolic dysregulation. Collectively, our results suggest that lactate metabolic signaling, production, accumulation or downstream may represents a potential therapeutic strategy for limiting adverse cardiac remodeling after MI.
- Open Access
- 24 June 2026
- Published by Portland Press Ltd. in Clinical Science
- Vol. 140 (7) , 1473-1496
Cardiometabolic regulation by adipocyte-derived leptin and the brain melanocortin system
Tonic activation of central nervous system (CNS) leptin receptors (LepRs) and melanocortin 4 receptors (MC4Rs) is critical for maintaining normal cardiometabolic function. Deficiency of CNS LepR or MC4R signaling causes severe obesity and is accompanied by multiple metabolic abnormalities including insulin resistance, glucose intolerance, and hyperlipidemia that are only partially explained by obesity. Defective LepR and MC4R signaling also causes dysfunction of the sympathetic nervous system (SNS) and blood pressure (BP) regulation. Hyperleptinemia and activation of the CNS melanocortin system in obesity are important compensatory mechanisms that attenuate abnormalities of glucose and lipid metabolism but may also contribute to SNS activation and increased BP. Despite potentially adverse effects of increases in SNS activity and BP, pharmacological activation of brain LepRs and MC4Rs may provide an important therapeutic approach for protecting target organs, such as the heart, kidneys, and brain, from ischemic injury by improving mitochondrial function and ATP production. However, additional preclinical studies are needed to address mechanistic questions before clinical studies are begun to test the effectiveness of leptin and MC4R agonists for treating people with ischemic injury of target organs.
- 24 June 2026
- Published by Portland Press Ltd. in Clinical Science
- Vol. 140 (7) , 1473-1496
Open AccessCardiometabolic regulation by adipocyte-derived leptin and the brain melanocortin system
Tonic activation of central nervous system (CNS) leptin receptors (LepRs) and melanocortin 4 receptors (MC4Rs) is critical for maintaining normal cardiometabolic function. Deficiency of CNS LepR or MC4R signaling causes severe obesity and is accompanied by multiple metabolic abnormalities including insulin resistance, glucose intolerance, and hyperlipidemia that are only partially explained by obesity. Defective LepR and MC4R signaling also causes dysfunction of the sympathetic nervous system (SNS) and blood pressure (BP) regulation. Hyperleptinemia and activation of the CNS melanocortin system in obesity are important compensatory mechanisms that attenuate abnormalities of glucose and lipid metabolism but may also contribute to SNS activation and increased BP. Despite potentially adverse effects of increases in SNS activity and BP, pharmacological activation of brain LepRs and MC4Rs may provide an important therapeutic approach for protecting target organs, such as the heart, kidneys, and brain, from ischemic injury by improving mitochondrial function and ATP production. However, additional preclinical studies are needed to address mechanistic questions before clinical studies are begun to test the effectiveness of leptin and MC4R agonists for treating people with ischemic injury of target organs.
- Open Access
- 1 June 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 330 (6) , H1827-H1840
Parental obesity exacerbates cognitive dysfunction and cardiac vulnerability in offspring of an Alzheimer disease model
Parental obesity is associated with worsened cognitive performance and male-specific impairments in cardiac metabolism and function in AD-susceptible offspring, highlighting developmental programming as a modifier of heart-brain vulnerability.
- 1 June 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 330 (6) , H1827-H1840
Open AccessParental obesity exacerbates cognitive dysfunction and cardiac vulnerability in offspring of an Alzheimer disease model
Parental obesity is associated with worsened cognitive performance and male-specific impairments in cardiac metabolism and function in AD-susceptible offspring, highlighting developmental programming as a modifier of heart-brain vulnerability.
- Open Access
- 27 February 2026
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 138 (5) , e326878
Leptin Activates Brain-BAT-Heart Crosstalk to Promote Cardiac Protection
BACKGROUND: Cardiovascular disease remains the leading cause of death worldwide, with coronary artery disease being the primary contributor. Our recent studies suggest that activation of LepRs (leptin receptors) in the brain can improve cardiac function after myocardial infarction. However, the mechanism by which this cardioprotective effect is transmitted from the brain to the heart remains unclear. We hypothesize that brain LepR activation stimulates brown adipose tissue (BAT) to secrete extracellular vesicles (EVs) enriched with cardioprotective factors. These EVs may safeguard the heart by modulating cardiac mitochondrial function and collagen deposition. METHODS: Sprague-Dawley rats with BAT intact, BAT ablation, or BAT sympathetic denervation were implanted with an intracerebroventricular cannula for continuous leptin or vehicle delivery over 28 days after cardiac ischemia-reperfusion injury. Cardiac function was assessed weekly via echocardiography and by ventricular catheterization at the end of the protocol. EVs were isolated from BAT for analysis. Rab27a (Ras-related protein Rab-27A), a protein required for EV release, was knocked down using adeno-associated virus, and EV tracking was conducted using a double fluorescent reporter mouse model. RESULTS: Our findings indicate that BAT ablation or BAT sympathetic denervation diminishes the cardioprotective effects of brain LepR activation. We also observed an increased concentration of EVs within the BAT of rats treated with intracerebroventricular leptin compared with vehicle-treated controls, an effect abolished by BAT denervation. Furthermore, knockdown of Rab27a in BAT reduced the cardioprotective benefits of brain LepR activation. MicroRNA miR-29c-3p was identified as a cargo of leptin-stimulated BAT-derived EVs and appears to play a key role in mitigating cardiac fibrosis after ischemia-reperfusion injury in leptin-treated animals. CONCLUSIONS: Activation of LepR in the brain protects the heart after ischemia-reperfusion injury via sympathetic-mediated BAT-derived EVs enriched with miR-29c-3p.
- 27 February 2026
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 138 (5) , e326878
Open AccessLeptin Activates Brain-BAT-Heart Crosstalk to Promote Cardiac Protection
BACKGROUND: Cardiovascular disease remains the leading cause of death worldwide, with coronary artery disease being the primary contributor. Our recent studies suggest that activation of LepRs (leptin receptors) in the brain can improve cardiac function after myocardial infarction. However, the mechanism by which this cardioprotective effect is transmitted from the brain to the heart remains unclear. We hypothesize that brain LepR activation stimulates brown adipose tissue (BAT) to secrete extracellular vesicles (EVs) enriched with cardioprotective factors. These EVs may safeguard the heart by modulating cardiac mitochondrial function and collagen deposition. METHODS: Sprague-Dawley rats with BAT intact, BAT ablation, or BAT sympathetic denervation were implanted with an intracerebroventricular cannula for continuous leptin or vehicle delivery over 28 days after cardiac ischemia-reperfusion injury. Cardiac function was assessed weekly via echocardiography and by ventricular catheterization at the end of the protocol. EVs were isolated from BAT for analysis. Rab27a (Ras-related protein Rab-27A), a protein required for EV release, was knocked down using adeno-associated virus, and EV tracking was conducted using a double fluorescent reporter mouse model. RESULTS: Our findings indicate that BAT ablation or BAT sympathetic denervation diminishes the cardioprotective effects of brain LepR activation. We also observed an increased concentration of EVs within the BAT of rats treated with intracerebroventricular leptin compared with vehicle-treated controls, an effect abolished by BAT denervation. Furthermore, knockdown of Rab27a in BAT reduced the cardioprotective benefits of brain LepR activation. MicroRNA miR-29c-3p was identified as a cargo of leptin-stimulated BAT-derived EVs and appears to play a key role in mitigating cardiac fibrosis after ischemia-reperfusion injury in leptin-treated animals. CONCLUSIONS: Activation of LepR in the brain protects the heart after ischemia-reperfusion injury via sympathetic-mediated BAT-derived EVs enriched with miR-29c-3p.
- 1 January 2026
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 330 (1) , R13-R22
Neonatal hyperoxia exposure does not exacerbate hypertension programmed by maternal obesity
Maternal obesity increases risk for preterm birth and neonatal oxygen exposure. We tested whether hyperoxia (80% O 2 , P3–P10) worsens maternal obesity-induced hypertension. At 14 wk, BP measured by telemetry showed that hyperoxia unexpectedly lowered BP in lean and obese offspring and attenuated cardiac dysfunction in obese offspring. These findings indicate that neonatal hyperoxia does not exacerbate maternal obesity-induced hypertension and may mitigate early cardiac dysfunction.
- 1 January 2026
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 330 (1) , R13-R22
Neonatal hyperoxia exposure does not exacerbate hypertension programmed by maternal obesity
Maternal obesity increases risk for preterm birth and neonatal oxygen exposure. We tested whether hyperoxia (80% O 2 , P3–P10) worsens maternal obesity-induced hypertension. At 14 wk, BP measured by telemetry showed that hyperoxia unexpectedly lowered BP in lean and obese offspring and attenuated cardiac dysfunction in obese offspring. These findings indicate that neonatal hyperoxia does not exacerbate maternal obesity-induced hypertension and may mitigate early cardiac dysfunction.
- Open Access
- 1 October 2025
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 329 (4) , H989-H990
Reply to Skalidis et al.
- 1 October 2025
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 329 (4) , H989-H990
Open AccessReply to Skalidis et al.
- Open Access
- 25 September 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9383
TRPC6 Deficiency Attenuates Mitochondrial and Cardiac Dysfunction in Heart Failure with Preserved Ejection Fraction Induced by High-Fat Diet Plus L-NAME
Transient receptor potential canonical channel type 6 (TRPC6), a non-selective cation channel that mediates Ca2+ influx, is expressed in the heart and implicated in pathological cardiac hypertrophy. However, the role of TRPC6 in regulating cardiac mitochondrial metabolism and contributing to development of HFpEF remains unclear. We examined whether TRPC6 deficiency prevents mitochondrial dysfunction and offers cardiac protection in a mouse model of HFpEF induced by high-fat diet (HFD) for 12 weeks combined with L-NAME administration during the final 8 weeks in TRPC6 knockout (KO) and wild-type (WT) control mice. Cardiac systolic and diastolic functions were assessed at baseline, 4 and 8 weeks after HFD+L-NAME. Dobutamine-induced stress test and treadmill exercise test were performed at the end of the protocol to evaluate cardiac reserve capacity and exercise tolerance. Mitochondrial oxygen consumption rate (OCR) and mitochondrial-derived reactive oxygen species (ROS) generation were examined in isolated cardiac fibers. WT mice subjected to HFD+L-NAME developed cardiac hypertrophy, diastolic dysfunction, and exercise intolerance, whereas TRPC6 KO mice, under the same conditions, maintained preserved diastolic function, exercise tolerance, and cardiac reserve. We also observed increased TRPC6 in mitochondria, as well as caspase-9 activation and impaired mitochondrial respiration in WT mice. In contrast, TRPC6 KO mice exhibited preserved mitochondrial OCR and attenuated mitochondrial ROS generation. In summary, TRPC6 deficiency prevents the development of HFpEF by mitigating diastolic dysfunction, preserving cardiac reserve capacity, and attenuating mitochondrial dysfunction.
- 25 September 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9383
Open AccessTRPC6 Deficiency Attenuates Mitochondrial and Cardiac Dysfunction in Heart Failure with Preserved Ejection Fraction Induced by High-Fat Diet Plus L-NAME
Transient receptor potential canonical channel type 6 (TRPC6), a non-selective cation channel that mediates Ca2+ influx, is expressed in the heart and implicated in pathological cardiac hypertrophy. However, the role of TRPC6 in regulating cardiac mitochondrial metabolism and contributing to development of HFpEF remains unclear. We examined whether TRPC6 deficiency prevents mitochondrial dysfunction and offers cardiac protection in a mouse model of HFpEF induced by high-fat diet (HFD) for 12 weeks combined with L-NAME administration during the final 8 weeks in TRPC6 knockout (KO) and wild-type (WT) control mice. Cardiac systolic and diastolic functions were assessed at baseline, 4 and 8 weeks after HFD+L-NAME. Dobutamine-induced stress test and treadmill exercise test were performed at the end of the protocol to evaluate cardiac reserve capacity and exercise tolerance. Mitochondrial oxygen consumption rate (OCR) and mitochondrial-derived reactive oxygen species (ROS) generation were examined in isolated cardiac fibers. WT mice subjected to HFD+L-NAME developed cardiac hypertrophy, diastolic dysfunction, and exercise intolerance, whereas TRPC6 KO mice, under the same conditions, maintained preserved diastolic function, exercise tolerance, and cardiac reserve. We also observed increased TRPC6 in mitochondria, as well as caspase-9 activation and impaired mitochondrial respiration in WT mice. In contrast, TRPC6 KO mice exhibited preserved mitochondrial OCR and attenuated mitochondrial ROS generation. In summary, TRPC6 deficiency prevents the development of HFpEF by mitigating diastolic dysfunction, preserving cardiac reserve capacity, and attenuating mitochondrial dysfunction.
- Open Access
- 1 May 2025
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 328 (5) , H1039-H1050
Parental obesity predisposes male and female offspring to exacerbated cardiac dysfunction and increased mortality after myocardial infarction
A major new finding of this study is that parental obesity markedly reduces survival rate and exacerbates cardiac dysfunction after myocardial infarction in their offspring, and this effect is independent of offspring sex.
- 1 May 2025
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 328 (5) , H1039-H1050
Open AccessParental obesity predisposes male and female offspring to exacerbated cardiac dysfunction and increased mortality after myocardial infarction
A major new finding of this study is that parental obesity markedly reduces survival rate and exacerbates cardiac dysfunction after myocardial infarction in their offspring, and this effect is independent of offspring sex.
- 1 December 2024
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 327 (6) , F957-F966
Chronic central nervous system leptin administration attenuates kidney dysfunction and injury in a model of ischemia/reperfusion-induced acute kidney injury
A major new finding of this study is that chronic activation of leptin receptors in the CNS markedly attenuates acute kidney injury and protects against severe renal dysfunction after ischemia/reperfusion, independently of leptin’s anorexic effects.
- 1 December 2024
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 327 (6) , F957-F966
Chronic central nervous system leptin administration attenuates kidney dysfunction and injury in a model of ischemia/reperfusion-induced acute kidney injury
A major new finding of this study is that chronic activation of leptin receptors in the CNS markedly attenuates acute kidney injury and protects against severe renal dysfunction after ischemia/reperfusion, independently of leptin’s anorexic effects.